1-4 of 4
Tomonobu Koizumi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience

Available to Purchase
Subject Area:
Karger e-Journal Backfile Collection 2023 , Further Areas , Oncology , Pharmacology
Taiki Okumura, Takuro Noguchi, Nodoka Sekiguchi, Takashi Kobayashi, Shintaro Kanda, Kouichi Ida, Tomonori Minagawa, Shigeo Tokumaru, Takeji Umemura, Tomonobu Koizumi
Journal: Chemotherapy
Chemotherapy (2023) 68 (2): 87–94.
https://doi.org/10.1159/000527377
Published Online: 06 June 2023
View articletitled, Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience
Open the PDF for Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience in another window
Journal Articles

Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression

Available to Purchase
Subject Area:
Karger e-Journal Backfile Collection 2023 , Further Areas , Oncology , Pharmacology
Tomonobu Koizumi, Shintaro Kanda, Takashi Kobayashi, Yoh-ichiro Iwasa, Akemi Matsuo
Journal: Chemotherapy
Chemotherapy (2023) 68 (3): 160–167.
https://doi.org/10.1159/000528592
Published Online: 28 December 2022
View articletitled, Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression
Open the PDF for Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression in another window
Journal Articles

Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Kei Sonehara, Kazunari Tateishi, Masamichi Komatsu, Hiroshi Yamamoto, Masayuki Hanaoka, Shintaro Kanda, Tomonobu Koizumi
Journal: Chemotherapy
Chemotherapy (2019) 64 (3): 129–137.
https://doi.org/10.1159/000502681
Published Online: 17 October 2019
View articletitled, Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute
Open the PDF for Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute in another window
Journal Articles

Dynamics of L-Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Daisuke Gomi, Aika Tanaka, Toshirou Fukushima, Takashi Kobayashi, Hirohide Matsushita, Nodoka Sekiguchi, Akiyuki Sakamoto, Shigeru Sasaki, Keiko Mamiya, Tomonobu Koizumi
Journal: Chemotherapy
Chemotherapy (2017) 62 (4): 225–230.
https://doi.org/10.1159/000464274
Published Online: 19 April 2017
View articletitled, Dynamics of L-Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy
Open the PDF for Dynamics of L-Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy in another window